<DOC>
	<DOC>NCT01124396</DOC>
	<brief_summary>Investigate safety/tolerability after repeated weekly doses intranasal administration of DSP-3025 comparator placebo to healthy male volunteers</brief_summary>
	<brief_title>DSP-3025 A Phase 1 Study of Healthy Male Volunteers</brief_title>
	<detailed_description />
	<criteria>Body mass index (BMI) between 18.5 and 25 kg/ m2 and a weight between 50 and 80 kg No clinically relevant abnormal findings Acute illness which requires medical intervention Definite or suspected personal history of adverse drug reactions or drug hypersensitivity Clinical relevant disease or disorder (past or present) A history of respiratory disorder(s) such as asthma</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>